Table 6.
Bacterial reference strains | Treated supernatants# |
|||||
---|---|---|---|---|---|---|
nBB536-CFS | nHN001-CFS | htBB536-CFS | htHN001-CFS | pkBB536-CFS | pkHN001-CFS | |
Escherichia coli ATCC 25922 | ++ | ++ | + | + | + | + |
Escherichia coli ATCC 35218 | ++ | ++ | ++ | + | + | + |
Klebsiella pneumoniae ATCC 700603 | ++ | ++ | ++ | ++ | + | + |
Pseudomonas aeruginosa ATCC 27853 | ++ | ++ | ++ | + | + | + |
Enterococcus faecalis ATCC 29212 | +++ | ++ | ++ | ++ | + | + |
Staphylococcus aureus ATCC 29213 | ++ | ++ | ++ | ++ | + | + |
Neutralized (pH = 7.0) cell-free supernatant from Bifidobacterium longum BB536 (nBB536-CFS) and Lactobacillus rhamnosus HN001 (nHN001-CFS); heat treated (121 °C, 15 min) cell-free supernatant from Bifidobacterium longum BB536 (htBB536-CFS) and Lactobacillus rhamnosus HN001 (htHN001-CFS); proteinase K treated cell-free supernatant from Bifidobacterium longum BB536 (pkBB536-CFS) and Lactobacillus rhamnosus HN001 (pkHN001-CFS). Agar diffusion method (ADM) +++ (very strong): diameter of inhibition zone ≥20.0 mm; ++ (strong): diameter of inhibition zone (20.0, 15.0] mm; + (weak): diameter of inhibition zone (15.0, 10.0] mm; - (no activity): diameter of inhibition zone <10.0 mm; punch diameter = 8.0 mm.